Wire · regulatory
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 29 July 2026 · Fusion42 review
Viatris has received U.S. FDA approval for Gwyn Lo™, a new once-weekly, low-dose estrogen contraceptive patch. The product, approved for women with a BMI under 30 kg/m², is expected to be commercially available in the US later this year.
This Wire brief sits within Fusion42's coverage of Femtech, and 2 sources have reported it.
◆ ◆ The Wire takeaway
The US market for non-daily contraception just gained a new competitor backed by a major pharmaceutical player. This approval via the 505(b)(2) pathway signals a faster regulatory route for challengers targeting known user pain-points like daily adherence.
◆ Coverage
2 sources · 29 Jul 2026
◆ Related on Wire
◆ Topics